glp-1 news today 2025 november 5 Weight-loss drugs such as Ozempic were in the headlines a lot in – and patent protections for these drugs expire in some countries in 2026. In this edition of #PeriodicGraphics in @ A network meta-analysis backed weight-loss

( B ) GLP-1 and GLP-1RAs act through the GLP-1R, which is a G protein coupled receptor

Cummings JL, Atri A, Feldman HH, et al

Wednesday (mid-week treat): Recipe 12, Cookie Dough Bliss

Biotin supports keratin infrastructure

Why Searches for Weight Loss Pills Are Increasing in 2026 Search interest for weight loss medications peaks every year between Christmas and New Year, making it the highest-intent period for weight loss-related queries

version, noted, Ozempic Proves Canada Must Update Dtc Advertising Rules. The point is that even if you live in Canada and receive health benefits through the province you live in, you are also a consumer who consumes media and youve been exposed to information and images published online, in print and via broadcast channels that have exposed you to the GLP-1 phenomenon